Viral reactivations and associated outcomes in the context of immune reconstitution after pediatric hematopoietic cell transplantation
Rick Admiraal(NHS Blood and Transplant), Jaap Jan Boelens(Wilhelmina Children's Hospital), Caroline A. Lindemans(University Medical Center Utrecht), Annemarie M. J. Wensing(University Medical Center Utrecht), Birgitta Versluys(University Medical Center Utrecht), Marc Bierings(University Medical Center Utrecht), Stefan Nierkens(Utrecht University), Coco de Koning(University Medical Center Utrecht), Tom F.W. Wolfs(KU Leuven)
Cited by 125
Related Papers
Gut microbiome–derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease
|Nature Immunology|2016|727
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial
|The Lancet|2012|376
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
|Journal of Clinical Oncology|2020|333